Zobrazeno 1 - 6
of 6
pro vyhledávání: '"May Sumi"'
Autor:
Huafeng Wang, May Sumi, Christine Huh, Fereshteh Parviz, Jessica Mastroianni, Jane Healy, Nicole Stevens, Leah Mitchell, Susanne Lang, Dan Kaufman, Robert Hollingsworth, David T. Rodgers
Publikováno v:
Cancer Research. 83:4059-4059
The full potential of cell therapy has yet to be realized in solid tumor indications and new approaches are urgently required. Macrophages are innate immune cells that can kill tumor cells and orchestrate the anti-tumor immune response. Macrophage ce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cad677ecd27b257967c493b392198b40
https://doi.org/10.1158/1538-7445.am2023-4059
https://doi.org/10.1158/1538-7445.am2023-4059
Autor:
Sean M. Carroll, Xiaomu Chen, Alexander Scholz, Norman M. Greenberg, May Sumi, Patricia Zuno-Mitchell, Kevin S. Williamson, Daniel Emerling, Gilson Baia, Felix Chu, David R. Minor, Jacob Glanville, Beatriz Millare, Jeremy Sokolove, Xiaobin Tang, Yann Chong Tan, Wayne Volkmuth, Amy Manning-Bog, Lawrence Steinman, Guy Cavet, Ngan Nguyen, Shuwei Jiang, Tito Serafini, Michael G Harbell, Dongkyoon Kim, Eldar Giladi, Danhui Zhang, Jeff DeFalco, William H. Robinson, Yvonne Leung, Gregg Espiritu Santo, Christine Dowd, Nicole Haaser
Publikováno v:
Clinical Immunology. 187:37-45
There is significant debate regarding whether B cells and their antibodies contribute to effective anti-cancer immune responses. Here we show that patients with metastatic but non-progressing melanoma, lung adenocarcinoma, or renal cell carcinoma exh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d765457617be03074d571b1d72499f3
https://doi.org/10.1016/j.clim.2017.10.002
https://doi.org/10.1016/j.clim.2017.10.002
Autor:
Bahram Valamehr, Samuel LaBarge, Yi-Shin Lai, Mochtar Pribadi, Suzanna Gasparian, Mandal Mili, Alma Gutierrez, Matthew Denholtz, Gloria Hsia, Jason ORourke, May Sumi, Bi-Huei Yang, Cokey Nguyen, Sandeep Kothapally Hanok, Alec Witty, Eric Sung, Amit R. Mehta, Raedun Clarke, Ramzey Abujarour, Eigen Peralta, Emily Carron, Thomas H. Lee, Emily Driver, Angela Gentile, Natalie Navarrete, David J. Robbins, Wen-I Yeh, Philip Chu, Chia-Wei Chang, Amanda D. Yzaguirre
Publikováno v:
Blood. 136:11-11
The development of chimeric antigen receptor (CAR) T cell therapeutics is widely recognized as a significant advancement for the treatment of cancer. However, several obstacles currently impede the broad use of CAR T cells, including the inherent pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6d8f69cdaa6921660b3c4c80e2deffbb
https://doi.org/10.1182/blood-2020-138930
https://doi.org/10.1182/blood-2020-138930
Autor:
Eric Sung, Thomas H. Lee, Cokey Nguyen, Yijia Pan, Eigen Peralta, May Sumi, Chia-Wei Chang, Bi-Huei Yang, Mochtar Pribadi, Wen-I Yeh, Dan Lu, Alec Witty
Publikováno v:
Blood. 136:32-32
Autologous chimeric antigen receptor (CAR)-T cell therapy has shown great promise in various hematologic malignancies. However, the complexities associated with immune cell evasion are prevalent causes of disease relapse in many cancers. With the adv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::be48e00da2dad3b7955a401d1ece1f26
https://doi.org/10.1182/blood-2020-141507
https://doi.org/10.1182/blood-2020-141507
Autor:
Xiaobin Tang, Yann Chong Tan, Wayne Volkmuth, Gilson Baia, Norman M. Greenberg, Daniel Emerling, Lawrence Steinman, Jonathan Benjamin, Ngan Nguyen, Alexander Scholz, Jacob Glanville, Judevin Lugar Sapugay, Michael Harbell, David R. Minor, Guy Cavet, Jeremy Sokolove, Nicole Haaser, Sean M. Carroll, Xiaomu Chen, Gregg Espiritu Santo, May Sumi, Dongkyoon Kim, William H. Robinson, Kevin S. Williamson, Danhui Zhang, Amy Manning-Bog, Tito Serafini, Beatriz Millare, Patricia Zuno, Christine Dowd, Shuwei Jiang, Ish Dhawan, Eldar Giladi, Jeff DeFalco, Felix Chu, Yvonne Leung
Publikováno v:
Cancer Research. 78:3966-3966
Background: The role of B cells and antibodies in anticancer immune responses may correlate with improved prognosis in several types of cancer. Indeed, tumor-reactive antibodies are detected in the blood of cancer patients, tumor-infiltrating B cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::01947ce94d7ebd1af08cfba26907365e
https://doi.org/10.1158/1538-7445.am2018-3966
https://doi.org/10.1158/1538-7445.am2018-3966
Autor:
William H. Robinson, Daniel Emerling, May Sumi, Felix Chu, Norman M. Greenberg, Gilson Baia, Wayne Volkmuth, Patricia Zuno-Mitchell, Danhui Zhang, Judevin Lugar Sapugay, Amy Manning-Bog, Beatriz Millare, Michael G Harbell, Iraz T Aydin, Sheila Fernandez, Alexander Scholz, Ngan Nguyen, Nicole Haaser, Jeff DeFalco, Jonathan Benjamin
Publikováno v:
Journal of Clinical Oncology. 36:e15015-e15015
e15015Background: It is unclear exactly how B cells and their antibodies (Abs) influence the anti-cancer immune response. We've proposed that anti-tumor Abs drive or amplify anti-tumor immune effec...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2cef4c70d3604c152055340e9cace030
https://doi.org/10.1200/jco.2018.36.15_suppl.e15015
https://doi.org/10.1200/jco.2018.36.15_suppl.e15015